Thomas Hawighorst
Publications by Year
Research Areas
Angiogenesis and VEGF in Cancer, Lymphatic System and Diseases, Protease and Inhibitor Mechanisms, Cancer, Hypoxia, and Metabolism, Estrogen and related hormone effects
Most-Cited Works
- → Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis(2001)1,744 cited
- → Concurrent Induction of Lymphangiogenesis, Angiogenesis, and Macrophage Recruitment by Vascular Endothelial Growth Factor-C in Melanoma(2001)387 cited
- → Thrombospondin-2: A potent endogenous inhibitor of tumor growth and angiogenesis(1999)301 cited
- → Activation of the Tie2 Receptor by Angiopoietin-1 Enhances Tumor Vessel Maturation and Impairs Squamous Cell Carcinoma Growth(2002)152 cited
- → Thrombospondin-1 selectively inhibits early-stage carcinogenesis and angiogenesis but not tumor lymphangiogenesis and lymphatic metastasis in transgenic mice(2002)92 cited
- → CD36-mediated activation of endothelial cell apoptosis by an N-terminal recombinant fragment of thrombospondin-2 inhibits breast cancer growth and metastasis in vivo(2010)86 cited
- Systemic inhibition of tumor growth and angiogenesis by thrombospondin-2 using cell-based antiangiogenic gene therapy.(2002)
- → The Angiogenesis Inhibitor Vasostatin does not Impair Wound Healing at Tumor-Inhibiting Doses(2001)64 cited
- → Expression of the Type-1 Repeats of Thrombospondin-1 Inhibits Tumor Growth Through Activation of Transforming Growth Factor-β(2004)58 cited
- → Medroxyprogesterone acetate inhibits the proliferation of estrogen- and progesterone-receptor negative MFM-223 human mammary cancer cells via the androgen receptor(1993)57 cited